BioXcel Therapeutics, Inc. — Director's Dealing 2019

Aug 14, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioXcel Therapeutics, Inc. (BTAI)
CIK: 0001720893
Period of Report: 2019-08-13

Reporting Person: Mehta Vimal (Director, CEO, President & Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-13	Common Stock	P	1000	$8.75	Acquired	6000	Direct